Titre |
A Randomized Web-Based Physical Activity Intervention Among Children and Adolescents With Acute Lymphoblastic Leukemia |
Protocole ID |
COG-ALTE1631 |
ClinicalTrials.gov ID |
NCT03223753 |
Type(s) de cancer |
Pédiatrique divers |
Phase |
Autres |
Type étude |
Autre |
Médicament |
Web-Based Physical Activity Intervention |
Institution |
CENTRE UNIVERSITAIRE DE SANTE MCGILL
HOPITAL DE MONTREAL POUR ENFANTS
1001 boul. Décarie , Montréal, QC, H4A 3J1
|
Ville |
Montréal |
Investigateur(trice) principal(e) |
Dre Sharon Abish
|
Coordonnateur(trice) |
Carla Centeno
514-412-4400 poste 28040
|
Statut |
Actif en recrutement |
Critètes d'éligibilité |
-
Patient must be a newly diagnosed ALL, in first remission
-
Patient must have completed curative chemotherapy within past 6 months at a Childrens Oncology Group (COG) institution
-
Patients must have a performance status corresponding to Eastern Cooperative Oncology Group (ECOG) scores of 0, 1, or 2; use Lansky for patients =< 16 years of age
-
At the time of consent, patient or parent/guardian reports less than 420 minutes of moderate to vigorous physical activity over the last week
-
Patient must have access to a smart phone with Android 4.3 or later or iOS 7.1 or later or computer (laptop/desktop) with a connection to the internet to create an account and be able to sync the Sqord device (accelerometer)
-
Patient and at least one parent/guardian are able to read and write English; at least 1 parent/guardian must be able to read and write English in order to assist the patient with using their Sqord account
|
Critètes d'exclusion |
-
Patients with previous hematopoietic stem cell transplant (HSCT)
-
Patients with significant concurrent disease, illness, psychiatric disorder or social issue that would compromise patient safety or compliance with protocol therapy, or interfere with consent, study participation, follow up, or interpretation of study results
-
Female patients who are pregnant are not eligible; women of childbearing potential require a negative pregnancy test
-
Female patient who is postmenarcheal has agreed to use an effective contraceptive method (including abstinence) for the duration of study participation
|